'Moderna Of China' Gets $700m Injection As Investors Bet Big On Domestic mRNA Vaccines

Meteoric Rise For Abogen

Despite a pending domestic approval for BioNTech/Fosun's COVID-19 vaccine, China’s apparent belief in another, domestically developed, mRNA vaccine sees a large group of investors pour hundreds of millions into a little-known private bioventure founded by an ex-Moderna scientist and poised to take on the US biotech.

SUZHOU-BASED ABOGEN GETS $700M TO PROGRESS ITS mRNA VACCINES AND THERAPEUTICS • Source: Alamy

Barely one month after the initiation of a final-stage clinical study, the developer of China's first domestically developed mRNA COVID-19 vaccine has now been showered with cash.

Private bioventure ABOGEN INC, founded just over two years ago, has grabbed a cash injection in a huge series C funding exceeding $700m, making it one of the best funded

More from China

More from Focus On Asia